Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

E K Rowinsky

Showing results (101-110 of 159) with videos related to

Pageof 16
Sort By:
Annals of Oncology : Official Journal of the European Society for Medical Oncology|March 27, 1999
A phase I study of docetaxel and 5-fluorouracil in patients with advanced solid malignanciesT Petit, C Aylesworth, H Burris, et al.
Cancer Research|November 1, 1991
Phase I and pharmacokinetic study of hepsulfam (NSC 329680)C B Hendricks, L B Grochow, E K Rowinsky, et al.
Cancer Research|June 1, 1990
Phase I study and pharmacodynamics of piroxantrone (NSC 349174), a new anthrapyrazoleA Hantel, R C Donehower, E K Rowinsky, et al.
Cancer Research|March 10, 1999
Enhanced antitumor activity of 6-hydroxymethylacylfulvene in combination with irinotecan and 5-fluorouracil in the HT29 human colon tumor xenograft modelC D Britten, S G Hilsenbeck, S G Eckhardt, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 1, 1996
Tissue and tumor distribution of C-penclomedine in ratsS O'Reilly, N R Hartman, S A Grossman, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|February 24, 2007
Assessment of erlotinib pharmacodynamics in tumors and skin of patients with head and neck cancerE Calvo, S N Malik, L L Siu, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 14, 1998
Sequence-dependent hematological toxicity associated with the 3-hour paclitaxel/cyclophosphamide doubletM J Kennedy, M L Zahurak, R C Donehower, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 1, 1994
Phase I and pharmacodynamic study of the topoisomerase I-inhibitor topotecan in patients with refractory acute leukemiaE K Rowinsky, A Adjei, R C Donehower, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|October 28, 1998
Activity of (-)-2'-deoxy-3'-oxacytidine (BCH-4556) against human tumor colony-forming unitsL L Siu, G Attardo, E Izbicka, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|September 1, 1992
Pharmacokinetics and pharmacodynamics of topotecan in patients with advanced cancerL B Grochow, E K Rowinsky, R Johnson, et al.
Pageof 16

Showing results (101-110 of 159) with videos related to

Sort By:
Pageof 16
Annals of Oncology : Official Journal of the European Society for Medical Oncology|March 27, 1999
A phase I study of docetaxel and 5-fluorouracil in patients with advanced solid malignanciesT Petit, C Aylesworth, H Burris, et al.
Cancer Research|November 1, 1991
Phase I and pharmacokinetic study of hepsulfam (NSC 329680)C B Hendricks, L B Grochow, E K Rowinsky, et al.
Cancer Research|June 1, 1990
Phase I study and pharmacodynamics of piroxantrone (NSC 349174), a new anthrapyrazoleA Hantel, R C Donehower, E K Rowinsky, et al.
Cancer Research|March 10, 1999
Enhanced antitumor activity of 6-hydroxymethylacylfulvene in combination with irinotecan and 5-fluorouracil in the HT29 human colon tumor xenograft modelC D Britten, S G Hilsenbeck, S G Eckhardt, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 1, 1996
Tissue and tumor distribution of C-penclomedine in ratsS O'Reilly, N R Hartman, S A Grossman, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|February 24, 2007
Assessment of erlotinib pharmacodynamics in tumors and skin of patients with head and neck cancerE Calvo, S N Malik, L L Siu, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 14, 1998
Sequence-dependent hematological toxicity associated with the 3-hour paclitaxel/cyclophosphamide doubletM J Kennedy, M L Zahurak, R C Donehower, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 1, 1994
Phase I and pharmacodynamic study of the topoisomerase I-inhibitor topotecan in patients with refractory acute leukemiaE K Rowinsky, A Adjei, R C Donehower, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|October 28, 1998
Activity of (-)-2'-deoxy-3'-oxacytidine (BCH-4556) against human tumor colony-forming unitsL L Siu, G Attardo, E Izbicka, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|September 1, 1992
Pharmacokinetics and pharmacodynamics of topotecan in patients with advanced cancerL B Grochow, E K Rowinsky, R Johnson, et al.
Pageof 16